Tg Therapeutics, Inc. · NASDAQ:TGTX
State Street Corp reported a 5.10% stake in Tg Therapeutics, Inc. (Schedule 13G)
Event Sep 30, 2025 · Filed Nov 10, 2025
State Street Corp reported a 5.10% stake in Tg Therapeutics, Inc., 8,100,619 shares, as a passive investor on Sep 30, 2025. Filed Nov 10, 2025 (Schedule 13G).
- Stake
- 5.10%
- Shares
- 8,100,619
- Intent
- Passive
- What changed
- Crossed above 5%
The filing in full
| Holder | Stake | Shares |
|---|---|---|
| STATE STREET CORPORATION | 5.10% | 8,100,619 |
Source
Related
- Tg Therapeutics, Inc.
- State Street Corp
- Tg Therapeutics, Inc. shareholders
- Schedule 13G · State Street Corp · May 13, 2025
- Form 4 · Charney Laurence N · Sep 14, 2026
- Form 4 · Charney Laurence N · Aug 7, 2026
- Schedule 13G · Vanguard Portfolio Management LLC · Apr 29, 2026
- Schedule 13G/A · The Vanguard Group · Mar 27, 2026
- Schedule 13G/A · BlackRock, Inc. · Apr 30, 2025